A Second Alzheimer’s Experimental Drug Fails

There have been several drug trials going on, with many anticipating successful results in the fight against Alzheimer’s. However, another high-profile experimental drug has failed to produce the desired outcomes. Continue reading to learn more.

Pfizer, J&J scrap Alzheimer’s studies as drug fails

Pfizer Inc and Johnson & Johnson scrapped further studies of one of the most anticipated experimental drugs for Alzheimer’s disease after it failed to help patients with the memory-robbing condition in a second high-profile clinical trial.

The companies said they would discontinue all other studies of the drug bapineuzumab in its intravenous (IV) form, including two more late stage trials and follow-up extension studies, in patients with mild to moderate Alzheimer’s.

The result marked the second such late-stage failure announced in recent weeks and was especially disappointing as bapineuzumab had been given a better chance of success in the patients studied in the second trial.

If successful, bapineuzumab would have been the first drug to fight the progression of the debilitating brain disease.

Attention will now turn to solanezumab, a similar drug being developed by Eli Lilly & Co that is also considered a long-shot to succeed, but will still carry fading hopes at least until late-stage test results are released later this year.

Continue reading HERE.

To learn about using our free Care Advisor service for senior home care, and access our Provider Network of licensed, insured agencies, visit us at Advocare. No fee or contract is necessary to use the services of our Care Advisor. A Certified Senior Advisor will discuss your care needs, develop a profile of the best candidate, and schedule interviews with potential caregivers from multiple agencies. Our unique model allows the agencies to compete for your business and helps you choose the best caregiver for the best price.

We help families in South Florida with care management in the Boca Raton, Boynton Beach, Delray Beach and Palm Beach areas.

Comments are closed.